Title:
NEW ARYLSULFONAMIDE COMPOUND FOR TREATMENT OF OBESITY, TYPE II DIABETES AND CNS-DISORDER
Document Type and Number:
Japanese Patent JP2011016801
Kind Code:
A
Abstract:
To provide a new arylsulfonamide compound for prevention and treatment of obesity, type II diabetes and central nervous system diseases.
There is provided a substituted bis-arylsulfonamide compound expressed by formula (II) or its pharmaceutically acceptable salt. In formula (II), two of R9, R12 and R14 are H; the remaining R9, R12 or R14 is an N-containing substituent or the like; R13 is piperazine or the like; and Y is H, alkyl, an aromatic ring or the like.
Inventors:
CALDIROLA PATRIZIA
BREMBERG ULF
JENSEN ANNIKA
JOHANSSON GARY
MOTT ANDREW
SUTIN LORI
TEJBRANT JAN
BREMBERG ULF
JENSEN ANNIKA
JOHANSSON GARY
MOTT ANDREW
SUTIN LORI
TEJBRANT JAN
Application Number:
JP2010157953A
Publication Date:
January 27, 2011
Filing Date:
July 12, 2010
Export Citation:
Assignee:
PROXIMAGEN LTD
International Classes:
C07D215/36; A61K31/407; A61K31/42; A61K31/495; A61K31/496; A61K31/4985; A61K31/551; A61P3/04; A61P3/10; A61P43/00; C07D233/56; C07D243/08; C07D261/10; C07D295/12; C07D295/135; C07D401/12; C07D409/14; C07D413/12; C07D487/04; C07D487/08
Attorney, Agent or Firm:
Mitsuo Tanaka
Hiroshi Yamazaki
Kenji Tomita
Mina Shiga
Masayuki Nakagawa
Fumio Inai
Hiroshi Yamazaki
Kenji Tomita
Mina Shiga
Masayuki Nakagawa
Fumio Inai